1:30 – 4:30 p.m.
US Geological Survey, Biological Informatics Office
12201 Sunrise Valley Drive , Room 4A322 (Fourth Floor)
Reston , VA 20192  

Welcome and Introductions Cotter/Spengler

Review Agenda Spengler/Cotter

Briefings

• International Cooperative Biodiversity Groups (ICBG)(Note 1) Dr. Joshua Rosenthal, ICBG Program Director, Fogarty International Center, National Institutes of Health
• Monitoring Science and Technology Symposium Dr. Sidney Draggan, Senior Science & Science Policy Advisor, Office of Asst Administrator for R&D, U.S. Environmental Protection Agency

Discussion Items

• Reports from/to GBIF7 in Japan Cotter/Attendees
• Nominations for Key Scientific & Technical Positions Cotter/Carroll
• Development of US GBIF Node
  • GBIF Node Managers: Status and Plans Mike Frame
  • Development of Next Steps All
• Strategic Planning for BioEco for FY04 Cotter/Spengler/All
  • Review of Mission Statement and Membership
  • Review of Potential Areas of Interest

Information Items

• FY04 Budget and Congressional Update All
• Agency Update Roundtable All

Minutes and Action Items Review Carroll

Other/New Business All

Next Meeting Spengler/Cotter

Note 1. The International Cooperative Biodiversity Groups (ICBG) Program is a unique effort that addresses the interdependent issues of drug discovery, biodiversity conservation, and sustainable economic growth. Efforts to examine the medicinal potential of the earth’s plants, animals, and microorganisms are urgently needed, since enduring habitat destruction and the resulting diminishment of biodiversity will make it increasingly difficult to do so in the future. Forty to fifty percent of currently used drugs have an origin in natural products.